New MDIC CEO Talks NEST, Case For Quality, CMS, And More
Executive Summary
Two months into the job, Medical Device Innovation Consortium CEO Pamela Goldberg talks about the organization's work running the NEST Coordinating Center, its efforts to engage the Medicare agency, early feasibility studies and its work with US FDA on Case for Quality.
You may also be interested in...
J&J Chief Medical Officer To Lead MDIC Board Of Directors
Jijo James, a top Johnson & Johnson executive, will succeed CVRx CEO Nadim Yared as the next chair of MDIC next summer.
After AdvaMed, Yared Takes Helm Of MDIC Board
CVRx CEO Nadim Yared has moved up on the board of directors at the Medical Device Innovation Consortium as its new chair. The public-private partnership group that formed in 2012 has been effective in working with the US Food and Drug Administration to develop new regulations.
Preferential Treatment: US FDA Asks Patients For Their Input
As the agency continues to incorporate more patient-preference data into its regulatory process, it is asking stakeholders on the kinds of diseases and other factors it should consider when evaluating patient-preference information. The feedback is ultimately meant to inform regulators and sponsors about what patients want as they develop products.